Cargando…

A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity

PURPOSE: To investigate the emerging role of Tc-99m-labeled diphosphonate (Tc-99m-DPD) uptake quantification by SPECT/CT in fibrous dysplasia (FD) bone lesions and its correlation with biological bone turnover markers (BTMs) of disease activity. MATERIALS AND METHODS: Seven patients (49 ± 16 years)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jreige, Mario, Hall, Nicolas, Becce, Fabio, Aubry-Rozier, Bérengère, Gonzalez Rodriguez, Elena, Schaefer, Niklaus, Prior, John O., Nicod Lalonde, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732018/
https://www.ncbi.nlm.nih.gov/pubmed/36507503
http://dx.doi.org/10.3389/fmed.2022.1050854
_version_ 1784846034526011392
author Jreige, Mario
Hall, Nicolas
Becce, Fabio
Aubry-Rozier, Bérengère
Gonzalez Rodriguez, Elena
Schaefer, Niklaus
Prior, John O.
Nicod Lalonde, Marie
author_facet Jreige, Mario
Hall, Nicolas
Becce, Fabio
Aubry-Rozier, Bérengère
Gonzalez Rodriguez, Elena
Schaefer, Niklaus
Prior, John O.
Nicod Lalonde, Marie
author_sort Jreige, Mario
collection PubMed
description PURPOSE: To investigate the emerging role of Tc-99m-labeled diphosphonate (Tc-99m-DPD) uptake quantification by SPECT/CT in fibrous dysplasia (FD) bone lesions and its correlation with biological bone turnover markers (BTMs) of disease activity. MATERIALS AND METHODS: Seven patients (49 ± 16 years) with a confirmed diagnosis of FD were included in this retrospective study. Bone scans with Tc-99m-DPD and quantitative SPECT/CT (xSPECT/CT) were performed. SUV(max) (maximum standard unit value) and SUV(mean) (mean standard unit value) were measured in all FD bone lesions. The skeletal burden score (SBS) was assessed on planar scintigraphy and multiplied by mean SUV(max) and SUV(mean) to generate two new parameters, SBS_SUV(max) and SBS_SUV(mean), respectively. Planar and xSPECT/CT quantitative measures were correlated with biological BTMs of disease activity, including fibroblast growth factor 23 (FGF-23), alkaline phosphatase (ALP), procollagen 1 intact N-terminal propeptide (P1NP) and C-terminal telopeptide (CTX), as well as scoliosis angle measured on radiographs. Statistical significance was evaluated with Spearman’s correlations. RESULTS: A total of 76 FD bone lesions were analyzed, showing an average SUV(max) and SUV(mean) (g/mL) of 13 ± 7.3 and 8 ± 4.5, respectively. SBS, SBS_SUV(max) and SBS_SUV(mean) values were 30.8 ± 25.6, 358 ± 267 and 220.1 ± 164.5, respectively. Mean measured values of FGF-23 (pg/mL), ALP (U/L), P1NP (μg/L) and CTX (pg/mL) were 98.4 (22–175), 283.5 (46–735), 283.1 (31–1,161) and 494 (360–609), respectively. Mean scoliosis angle was 15.7 (7–22) degrees. We found a very strong positive correlation between planar-derived SBS and CTX (r = 0.96, p = 0.010), but no significant correlation between SUV(max) or SUV(mean) and biological BTMs. SBS_SUV(max) showed a strong to very strong positive correlation with CTX (ρ = 0.99, p = 0.002), FGF-23 (ρ = 0.91, p = 0.010), ALP (ρ = 0.82, p = 0.020), and P1NP (ρ = 0.78, p = 0.039), respectively. CONCLUSION: This study showed that biological BTMs are significantly correlated with diphosphonate uptake on bone scan, quantified by a new parameter combining information from both planar and quantitative SPECT/CT. Further analysis of bone scan quantitative SPECT/CT data in a larger patient population might help better characterize the skeletal disease burden in FD, and guide treatment and follow-up.
format Online
Article
Text
id pubmed-9732018
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97320182022-12-10 A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity Jreige, Mario Hall, Nicolas Becce, Fabio Aubry-Rozier, Bérengère Gonzalez Rodriguez, Elena Schaefer, Niklaus Prior, John O. Nicod Lalonde, Marie Front Med (Lausanne) Medicine PURPOSE: To investigate the emerging role of Tc-99m-labeled diphosphonate (Tc-99m-DPD) uptake quantification by SPECT/CT in fibrous dysplasia (FD) bone lesions and its correlation with biological bone turnover markers (BTMs) of disease activity. MATERIALS AND METHODS: Seven patients (49 ± 16 years) with a confirmed diagnosis of FD were included in this retrospective study. Bone scans with Tc-99m-DPD and quantitative SPECT/CT (xSPECT/CT) were performed. SUV(max) (maximum standard unit value) and SUV(mean) (mean standard unit value) were measured in all FD bone lesions. The skeletal burden score (SBS) was assessed on planar scintigraphy and multiplied by mean SUV(max) and SUV(mean) to generate two new parameters, SBS_SUV(max) and SBS_SUV(mean), respectively. Planar and xSPECT/CT quantitative measures were correlated with biological BTMs of disease activity, including fibroblast growth factor 23 (FGF-23), alkaline phosphatase (ALP), procollagen 1 intact N-terminal propeptide (P1NP) and C-terminal telopeptide (CTX), as well as scoliosis angle measured on radiographs. Statistical significance was evaluated with Spearman’s correlations. RESULTS: A total of 76 FD bone lesions were analyzed, showing an average SUV(max) and SUV(mean) (g/mL) of 13 ± 7.3 and 8 ± 4.5, respectively. SBS, SBS_SUV(max) and SBS_SUV(mean) values were 30.8 ± 25.6, 358 ± 267 and 220.1 ± 164.5, respectively. Mean measured values of FGF-23 (pg/mL), ALP (U/L), P1NP (μg/L) and CTX (pg/mL) were 98.4 (22–175), 283.5 (46–735), 283.1 (31–1,161) and 494 (360–609), respectively. Mean scoliosis angle was 15.7 (7–22) degrees. We found a very strong positive correlation between planar-derived SBS and CTX (r = 0.96, p = 0.010), but no significant correlation between SUV(max) or SUV(mean) and biological BTMs. SBS_SUV(max) showed a strong to very strong positive correlation with CTX (ρ = 0.99, p = 0.002), FGF-23 (ρ = 0.91, p = 0.010), ALP (ρ = 0.82, p = 0.020), and P1NP (ρ = 0.78, p = 0.039), respectively. CONCLUSION: This study showed that biological BTMs are significantly correlated with diphosphonate uptake on bone scan, quantified by a new parameter combining information from both planar and quantitative SPECT/CT. Further analysis of bone scan quantitative SPECT/CT data in a larger patient population might help better characterize the skeletal disease burden in FD, and guide treatment and follow-up. Frontiers Media S.A. 2022-11-25 /pmc/articles/PMC9732018/ /pubmed/36507503 http://dx.doi.org/10.3389/fmed.2022.1050854 Text en Copyright © 2022 Jreige, Hall, Becce, Aubry-Rozier, Gonzalez Rodriguez, Schaefer, Prior and Nicod Lalonde. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Jreige, Mario
Hall, Nicolas
Becce, Fabio
Aubry-Rozier, Bérengère
Gonzalez Rodriguez, Elena
Schaefer, Niklaus
Prior, John O.
Nicod Lalonde, Marie
A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity
title A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity
title_full A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity
title_fullStr A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity
title_full_unstemmed A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity
title_short A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity
title_sort novel approach for fibrous dysplasia assessment using combined planar and quantitative spect/ct analysis of tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732018/
https://www.ncbi.nlm.nih.gov/pubmed/36507503
http://dx.doi.org/10.3389/fmed.2022.1050854
work_keys_str_mv AT jreigemario anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT hallnicolas anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT beccefabio anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT aubryrozierberengere anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT gonzalezrodriguezelena anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT schaeferniklaus anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT priorjohno anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT nicodlalondemarie anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT jreigemario novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT hallnicolas novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT beccefabio novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT aubryrozierberengere novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT gonzalezrodriguezelena novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT schaeferniklaus novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT priorjohno novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity
AT nicodlalondemarie novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity